Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2006 1
2008 2
2009 4
2010 3
2011 1
2013 2
2014 3
2015 2
2017 3
2018 3
2019 1
2020 3
2021 3
2022 2
2023 1
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

24 results

Results by year

Filters applied: . Clear all
Page 1
Ipragliflozin Improves the Hepatic Outcomes of Patients With Diabetes with NAFLD.
Takahashi H, Kessoku T, Kawanaka M, Nonaka M, Hyogo H, Fujii H, Nakajima T, Imajo K, Tanaka K, Kubotsu Y, Isoda H, Oeda S, Kurai O, Yoneda M, Ono M, Kitajima Y, Tajiri R, Takamori A, Kawaguchi A, Aishima S, Kage M, Nakajima A, Eguchi Y, Anzai K. Takahashi H, et al. Among authors: kitajima y. Hepatol Commun. 2022 Jan;6(1):120-132. doi: 10.1002/hep4.1696. Epub 2021 Jun 17. Hepatol Commun. 2022. PMID: 34558835 Free PMC article. Clinical Trial.
Porphyromonas gingivalis impairs glucose uptake in skeletal muscle associated with altering gut microbiota.
Watanabe K, Katagiri S, Takahashi H, Sasaki N, Maekawa S, Komazaki R, Hatasa M, Kitajima Y, Maruyama Y, Shiba T, Komatsu K, Ohsugi Y, Tanaka K, Matsuzawa A, Hirota T, Tohara H, Eguchi Y, Anzai K, Hattori A, Iwata T. Watanabe K, et al. Among authors: kitajima y. FASEB J. 2021 Feb;35(2):e21171. doi: 10.1096/fj.202001158R. Epub 2020 Nov 16. FASEB J. 2021. PMID: 33197074
Case Report: Metreleptin and SGLT2 Inhibitor Combination Therapy Is Effective for Acquired Incomplete Lipodystrophy.
Nagayama A, Ashida K, Watanabe M, Moritaka K, Sonezaki A, Kitajima Y, Takahashi H, Yoshinobu S, Iwata S, Yasuda J, Hasuzawa N, Ozono S, Motomura S, Nomura M. Nagayama A, et al. Among authors: kitajima y. Front Endocrinol (Lausanne). 2021 May 31;12:690996. doi: 10.3389/fendo.2021.690996. eCollection 2021. Front Endocrinol (Lausanne). 2021. PMID: 34135866 Free PMC article.
Biphasic effect of alcohol intake on the development of fatty liver disease.
Takahashi H, Ono M, Hyogo H, Tsuji C, Kitajima Y, Ono N, Eguchi T, Fujimoto K, Chayama K, Saibara T, Anzai K, Eguchi Y. Takahashi H, et al. Among authors: kitajima y. J Gastroenterol. 2015 Nov;50(11):1114-23. doi: 10.1007/s00535-015-1058-z. Epub 2015 Mar 3. J Gastroenterol. 2015. PMID: 25733100
Periodontal pathogenic bacteria, Aggregatibacter actinomycetemcomitans affect non-alcoholic fatty liver disease by altering gut microbiota and glucose metabolism.
Komazaki R, Katagiri S, Takahashi H, Maekawa S, Shiba T, Takeuchi Y, Kitajima Y, Ohtsu A, Udagawa S, Sasaki N, Watanabe K, Sato N, Miyasaka N, Eguchi Y, Anzai K, Izumi Y. Komazaki R, et al. Among authors: kitajima y. Sci Rep. 2017 Oct 24;7(1):13950. doi: 10.1038/s41598-017-14260-9. Sci Rep. 2017. PMID: 29066788 Free PMC article.
Upper limit of normal serum alanine aminotransferase levels in Japanese subjects.
Tanaka K, Hyogo H, Ono M, Takahashi H, Kitajima Y, Ono N, Eguchi T, Fujimoto K, Chayama K, Saibara T, Anzai K, Eguchi Y; Japan Study Group of Non-alcoholic Fatty Liver Disease (JSG-NAFLD). Tanaka K, et al. Among authors: kitajima y. Hepatol Res. 2014 Nov;44(12):1196-207. doi: 10.1111/hepr.12293. Epub 2014 Feb 17. Hepatol Res. 2014. PMID: 24372862
24 results